Nuclear Imaging Devices Market Insight, Size, Value, Demand, Covid 19 Pandemic Impact, Regional Framework, Research Methodology and Forecast To 2030
Market Highlights
The global Nuclear
Imaging Devices Market is expected to grow significantly over the forecast
period. It is projected to reach USD 2473.83 Million by 2030 at 5.10% CAGR
during the forecast period 2022-2030.
The increasing prevalence of cardiovascular
disorders is one of the key factors driving the nuclear imaging devices
market. As per the report published by the Centers for Disease Control and
Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least
one type of cardiovascular disease.
Various other factors such as the advancements in
radiotracers, acceptance of nuclear imaging devices in ambulatory settings,
increasing geriatric population, untapped emerging markets, rise in regulatory
approvals, and increasing investment on diagnostic imaging centers are also
expected to propel the growth of the market.
However, the high cost of the nuclear imaging device,
shorter half-life of radiopharmaceuticals can hamper market growth over
the forecast period.
Segmentation
The global nuclear imaging devices market is segmented based
on technology, application, end user, and region.
·
The global market for nuclear imaging
devices, by technology, is segmented into positron emission tomography
(PET), single photon emission computed tomography (SPECT), and planar
scintigraphy. The single-photon-emission computed tomography (SPECT) are
further classified as hybrid
SPECT systems and standalone SPECT systems.
·
Based on application, the market is
segmented into oncology, cardiology, neurology, and others.
·
Based on end user, the market is
segmented into hospitals, diagnostic imaging centers, and others.
·
The diagnostic imaging centers segment is
expected to witness the fastest growth over the forecast period due to rising
adoption of nuclear imaging in diagnostic centers.
Key Players
Some of the key players in the global nuclear imaging
devices market are Philips Healthcare, Digirad Corporation, Neusoft Medical
Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH,
CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General
Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical
Systems, Inc., Segamicorp, and others.
Regional Analysis
In the current scope of the study, the segments mentioned
above are covered into the four global regions, namely, the Americas, Europe,
Asia-Pacific, and the Middle East and African region.
The nuclear imaging devices market in the Americas has
further been segmented into North America and South America, with the North
American market divided into the US and Canada.
The European nuclear imaging devices market has been
segmented into Western Europe and Eastern Europe. Western Europe has been
classified as Germany, France, the UK, Italy, Spain, and the rest of Western
Europe. The nuclear imaging devices market in Asia-Pacific has been
segmented into Japan, China, India, South Korea, Australia, and the rest of
Asia-Pacific. The nuclear imaging devices market in the Middle East &
Africa has been segmented into the Middle East and Africa.
Related Report:
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment